Since 2009, Cure4CF has invested over $5 million in research that aim to deliver real breakthroughs for people with cystic fibrosis. We are Australia’s largest private funder of CF-focused research, and we fund only one thing: research that has a clear path to transform the lives of people with CF.

Our difference is clear:

• We fund only translational research — science proven in the lab, with a pathway to real-world clinical impact.
• Selection is rigorous — guided by our expert Independent Research Advisory Committee, with transparent governance and oversight.
• We back scientifically excellent, clinically relevant projects with the power to transform global CF care.

Right now, Australians with CF born between 2008 and 2012 have a median survival age of just 47 years. Modulators help many, but not all. They don’t end the relentless toll of CF, and the lifetime treatment cost is well over $1 million per patient. This is why Cure4CF exists to support research that changes this reality.